Presence of antibodies in nasal mucosa suggest vaccine-induced immune protection at source of infection ...
NeoCart® Top-line Phase 3 Clinical Trial Data and Potential Biologics License Application Filing Remain ...
LONDON, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) ...
